Literature DB >> 16039124

Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.

Meizi He1, Dekai Yuan, Wei Lin, Ruifang Pang, Xiaolin Yu, Ming Yang.   

Abstract

Four new isoquinoline derivatives bearing guanidinium group or amino group-terminated side chain were synthesized to target the HIV-1 TAR element. Their abilities to bind TAR RNA and inhibit Tat-TAR RNA interaction were determined by CE analysis, a Tat-dependent HIV-1 LTR-driven CAT assay and SIV-induced syncytium evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039124     DOI: 10.1016/j.bmcl.2005.01.068

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.

Authors:  Nihar Ranjan; Sunil Kumar; Derrick Watkins; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2013-08-14       Impact factor: 2.823

Review 2.  Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin.

Authors:  Shiraz Mujtaba; Ming-Ming Zhou
Journal:  Methods       Date:  2010-09-07       Impact factor: 3.608

3.  Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1.

Authors:  Tatiana Ammosova; Maxim Platonov; Venkat R K Yedavalli; Yuri Obukhov; Victor R Gordeuk; Kuan-Teh Jeang; Dmytro Kovalskyy; Sergei Nekhai
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

4.  Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.

Authors:  Matthew S Lalonde; Michael A Lobritz; Annette Ratcliff; Mastooreh Chamanian; Zafiria Athanassiou; Mudit Tyagi; Julian Wong; John A Robinson; Jonathan Karn; Gabriele Varani; Eric J Arts
Journal:  PLoS Pathog       Date:  2011-05-19       Impact factor: 6.823

5.  Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.

Authors:  Megan L Kelly; Chia-Chieh Chu; Honglue Shi; Laura R Ganser; Hal P Bogerd; Kelly Huynh; Yuze Hou; Bryan R Cullen; Hashim M Al-Hashimi
Journal:  RNA       Date:  2020-10-07       Impact factor: 5.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.